PURPOSE:To provide the subject remedy capable of decomposing triglycerides contained in ultralow density lipoprotein is blood and chylomicron to metabolize neutral fats to be stored, by containing a specific pyrimidine derivative (salt) as an active ingrediate. CONSTITUTION:The objective tready contains as an active ingredient a pyrimidine (salt) of formula I [Y is formula II or III (R2 is H or halogen); R1 is H, lower alkyl or aryl; R3 is lower alkyl or cyloalkyl; R4 is H, lower alkyl, OH or halogen (but when Y is formula III and the dotted line exhibits a double band); R5 is H, lower alkyl, OH, oxo or halogen (but when Y is formula III and the dotted line exhibits a double bond); R6 is H, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or aralkyl; the dotted line is a single bond or double band]. The pyrimidine of formula I is usually administered in a dose of 10-1000mg/day orally and in a dose of 10-500mg/time parenterally.
展开▼
机译:目的:通过提供特定的嘧啶衍生物(盐)作为活性成分,为提供能够分解超低密度脂蛋白中所含甘油三酸酯的血液和乳糜微粒,以代谢待储存的中性脂肪,以提供一种能够使本药分解的方法。组成:目标胎面含有式I [Y为式II或III(R 2为H或卤素)的嘧啶(盐)作为活性成分。 R 1为H,低级烷基或芳基; R 3为低级烷基或环烷基; R 4为H,低级烷基,OH或卤素(但当Y为式III且虚线显示双带时); R 5为H,低级烷基,OH,氧代或卤素(但当Y为式III且虚线表示双键时); R 6为H,烷基,烯基,炔基,环烷基,芳基或芳烷基;虚线是单键或双带]。式I的嘧啶通常以10-1000mg /天的剂量经口和以10-500mg /次的剂量经肠胃外给药。
展开▼